Report forecast the autoimmune diseases market in the
US to grow at a CAGR of 6.17% over the period 2014-2019.
Autoimmune diseases are caused by aggravation of the
immune system. Autoimmune diseases can last for months or even years.
Autoimmune reactions occur when the immune system produces autoantibodies that
attack and destroy healthy tissues in the body rather than infectious agents.
These autoantibodies cause inflammation, pain, and organ damage. It is also
known as a disease of flare-ups and remissions, and can range from mild to
life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune
diseases can affect the cardiovascular system, brain, nerves, musculoskeletal
system, skin, lungs, kidneys, glands, or joints. They are caused by genetic,
infectious, and environmental factors. According to NIH, there are more than 80
clinically different autoimmune diseases. Some of the common types of
autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple
sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.
The report includes the present scenario and the growth
prospects of the autoimmune diseases market in the US for the period 2015-2019.
To calculate the market size, the report considers revenue generated from the
sales of various drugs used in the treatment of autoimmune diseases.
Autoimmune Diseases Market in US 2015-2019, has been
prepared based on an in-depth market analysis with inputs from industry
experts. It covers the market size and forecast for individual diseases as well
as the overall market and pipeline landscape. The report includes a discussion
of the key vendors operating in this market.
Key players in the Autoimmune Diseases Drugs Market
in the US: AbbVie, Amgen, Biogen, F. Hoffmann-La Roche and Janssen
Pharmaceuticals
Other Prominent Vendors in the market are:
Bitdefender, Fortinet, F-Secure, G DATA Software, McAfee, Panda Security,
PSafe, Sophos and Wontok
Key Market Driver
- Unmet Medical Needs
- For a full, detailed list, view our report
Key Market Challenge
- High Cost of Therapy
- For a full, detailed list, view our report
Key Market Trend
- Increase in Public Awareness
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 95 pages, “Autoimmune Diseases Market in the US 2015-2019” report
covers Executive Summary, List of Abbreviations, Scope of the Report, Market
Research Methodology, Introduction, Disease Overview, Market Landscape, Pipeline
Portfolio, Market Segmentation by Type of Diseases, Market Segmentation by Type
of Molecules, Market Segmentation by Route of Administration, Ankylosing
Spondylitis Market in the US, Crohn's Disease Market in the US, Multiple
Sclerosis Market in the US, Rheumatoid Arthritis Market in the US, Psoriasis
Market in the US, Systemic Lupus Erythematosus Market in the US, Buying
Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges,
Impact of Drivers and Challenges, Market Trends, Trends and their Impact,
Vendor Landscape, Key Vendor Analysis.
For
further information on this report, please visit-
http://mrr.cm/4D2
Find all Diseases
Reports at: http://www.marketresearchreports.com/diseases
No comments:
Post a Comment
Note: only a member of this blog may post a comment.